Overall survival benefit of Osimertinib and clinical value of upfront cranial local therapy in untreated EGFR‐mutant non‐small cell lung cancer with brain metastasis
Corresponding Author
Jianjiao Ni
Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
Correspondence
Jianjiao Ni, MD Department of Radiation Oncology, Fudan University Shanghai Cancer Center 270 Dong An Road, Shanghai, 200032 China Phone: +86-13761974092 Fax: +86-2164175242
Email: nijianjiao8@shca.org.cn
Zhengfei Zhu, MD Department of Radiation Oncology, Fudan University Shanghai Cancer Center 270 Dong An Road, Shanghai, 200032 China Phone: +86-18017312901 Fax: +86-2164175242
Email: fuscczzf@fudan.edu.cn
Search for more papers by this author
Comments (0)